Trump Forces AstraZeneca to Slash Drug Prices with Threat of 100% Tariffs
Key Takeaways
- AstraZeneca agreed to lower drug prices for Medicaid under most-favored-nation pricing.
- The deal includes listing discounted drugs on the government’s TrumpRx website.
- Trump threatened 100% tariffs on AstraZeneca drugs to secure the pricing agreement.
Trump's Drug Pricing Agreements
Former President Donald Trump announced a deal under which AstraZeneca became the second drugmaker to support his “Most Favored Nation” initiative.
“President Donald Trump on Friday said that pharmaceutical giant AstraZeneca has struck a deal to sell its drugs to the government’s Medicaid program at a discount, making it the second company to publicly agree to the Trump’s administration’s push for lower drug prices”
The company committed to selling to Medicaid at prices tied to the lowest paid in comparable countries and to offer direct-to-consumer discounts via the TrumpRx site.
Multiple outlets report that the pact follows a similar agreement with Pfizer and includes participation on TrumpRx, with discounts up to 80% on some chronic-disease medicines.
Trump and his aides credit sustained tariff pressure for bringing companies to the table, though the agreements’ detailed terms remain confidential and their full impact is unclear.
Trump's Tariff Strategy
Central to the story is Trump’s tariff leverage.
He warned manufacturers and foreign governments that noncompliance would trigger tariffs, while publicly arguing that U.S. prices would fall and overseas prices would rise toward a middle ground.
Multiple outlets also note AstraZeneca and Pfizer received a three-year tariff reprieve, underscoring that the threat — not immediate penalties — helped secure agreements.
However, the precise tariff level remains uncertain across sources; some describe generalized threats, others cite letters warning of rates as high as 200%, and no mainstream report confirms a fixed 100% tariff as the trigger.
AstraZeneca's Commitments and Benefits
AstraZeneca pledged significant price and production commitments, including discounts of up to 80% on certain drugs.
“The pharmaceutical giant will reportedly lower their drug prices to align with most favored nation status”
The company also agreed to MFN-linked Medicaid pricing and participation in the TrumpRx program.
Additionally, AstraZeneca plans a U.S. manufacturing expansion valued at roughly $50 billion.
This expansion includes a $4.5 billion plant in Virginia, which is expected to create about 3,600 jobs.
Multiple sources highlight that the companies received tariff reprieves, which the White House credits with helping to catalyze the deals.
Skepticism on Drug Pricing Claims
Experts and several outlets are skeptical about bold claims around the deal’s impact.
The Guardian reports Trump even floated “price cuts of up to 1,000%,” which experts call illogical and false.
CBS News notes Medicaid already has statutory “best price” protections and casts direct-to-patient moves as more branding than broad savings.
NewsBreak flags confidentiality and “mathematically questionable” claims.
NPR documents the up-to-80% discounts but not overarching savings for most insured patients.
Media Coverage on Pfizer Deal
WBFF touts “discounts of 50% to 100%” in a prior Pfizer deal and says Trump pushed Pfizer toward a $70 million U.S. investment.
NTD News reports a much larger $70 billion figure for Pfizer research and development.
Breitbart highlights a TrumpRX.gov launch in January 2026, whereas The Washington Post says “early next year.”
SSBCrack adds that the negotiations were influenced by the threat of tariffs.
CBS underscores legal and structural barriers that limit sweeping price reforms.
One outlet, Devdiscourse, contains no news content at all for this topic, underscoring uneven information quality.
More on USA
7th Circuit Upholds Illinois Protect Illinois Communities Act Ban on Semiautomatic Guns
12 sources compared
Indiana State Police Trooper Justin Heflin Shot During Pursuit; Suspect Kevin W. Meyers Found Dead
10 sources compared
Donald Trump Fires Election Assistance Commission Members, Leaving No Commissioners
12 sources compared
Eight Accused Of Planning Terror Attack At Casa Blanca UFC Freedom 250 Event
18 sources compared